UK begins AstraZeneca Covid-19 vaccine rollout with dialysis patient

82-year-old Brian Pinker receives the Oxford University/AstraZeneca Covid-19 vaccine from nurse Sam Foster at the Churchill Hospital in Oxford, England, Monday, Jan. 4, 2021. (Steve Parsons/Pool Photo via AP)

The UK's National Health Service (NHS) on Monday began rolling out the Oxford University vaccine developed by AstraZeneca as protection against COVID-19, with an 82-year-old Oxford-born dialysis patient becoming the first to receive the new jab.

Brian Pinker is among the first to be vaccinated by the Oxford University Hospital's (OUH) chief nurse, hailed as a major milestone in the phased vaccination programme being undertaken by the NHS as the Oxford jab became the second vaccine approved for rollout after the Pfizer/BioNTech vaccine.

A retired maintenance manager who has been having dialysis for kidney disease at the hospital for a number of years, Pinker said he was pleased to be getting protection against the virus, giving him peace of mind as he continues to receive treatment.

"I am so pleased to be getting the COVID-19 vaccine today and really proud that it is one that was invented in Oxford. The nurses, doctors and staff today have all been brilliant and I can now really look forward to celebrating my 48th wedding anniversary with my wife Shirley later this year, he said.

Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.

We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

Business Standard is now on Telegram.
For insightful reports and views on business, markets, politics and other issues, subscribe to our official Telegram channel